Glucose News and Research

RSS

Key facts about polycystic ovary syndrome

September marks Polycystic Ovary Syndrome (PCOS) awareness month and with this condition affecting millions of women in the world, there are some key facts about the condition to highlight that can affect a women's fertility when suffering with the disorder.

6 Sep 2012

More findings on genetic complexity behind type 2 diabetes

Using a new method, diabetes researchers at Lund University, Sweden, have been able to reveal more of the genetic complexity behind type 2 diabetes.

5 Sep 2012

Eco-friendly blood glucose monitor: an interview with Gemma Evans from Cambridge Consultants

It’s not really a question of how eco-friendly or un-eco-friendly current blood glucose meters (BGMs) are compared with, say, a fridge freezer or a Boeing 747.

5 Sep 2012

A-kinase anchoring proteins influence levels of glucose in the body

Scientists from the United States and Sweden have discovered a new control point that could be important as a drug target for the treatment of diabetes and other metabolic diseases.

4 Sep 2012

Herpes virus eventually impairs glucose regulation

The common herpes virus cytomegalovirus may be a risk factor for the development of Type 2 diabetes among elderly individuals, show study findings.

3 Sep 2012

Blood glucose mobile apps may present visual and physical obstacles for older adults

Diabetes is prevalent among adults aged 65 and older and can lead to a number of other serious health issues. Maintaining control of blood glucose levels is one of the most important actions diabetics can take to control their illness. New technology is designed to make self-monitoring easier and more accessible than ever before, but often tech products fail to accommodate some older users.

1 Sep 2012

Sleep apnea’s contribution to diabetic nephropathy needs attention

The effect of obstructive sleep apnea syndrome on the development of diabetic nephropathy requires investigation, say researchers.

31 Aug 2012

Healthy diets during infancy and early childhood can prevent obesity in future

Rats born to mothers fed high-fat diets but who get normal levels of fat in their diets right after birth avoid obesity and its related disorders as adults, according to new Johns Hopkins research.

31 Aug 2012

Nipro Diagnostics, NextGen enter agreement for TRUEresult blood glucose monitoring system

NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with Nipro Diagnostics, Inc. to integrate its TRUEresult blood glucose monitoring system into the NextGen Ambulatory EHR.

30 Aug 2012

Insulin glargine retards progression of atherosclerosis in high-risk people

A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.

27 Aug 2012

Understanding photoreceptor proteins could lead to cancer drug therapy

How does a plant know when to sprout a leaf, fold its petals or bloom? Why do humans experience jet lag after a trip abroad?

24 Aug 2012

Radiating fears over diabetes in childhood cancer survivors

People who undergo pancreatic irradiation during childhood cancer therapy are at an increased risk for developing diabetes later in life, report researchers.

24 Aug 2012

Researchers create new type of biosensor that can detect glucose in saliva, tears

Researchers have created a new type of biosensor that can detect minute concentrations of glucose in saliva, tears and urine and might be manufactured at low cost because it does not require many processing steps to produce.

24 Aug 2012

FDA warns consumers about potential health risks of two natural dietary supplements

The U.S. Food and Drug Administration today issued a new warning to consumers about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions.

22 Aug 2012

SSEA4+ marker helps identify and isolate precursors of insulin-producing pancreatic cells

For the millions of people worldwide with type 1 diabetes who cannot produce sufficient insulin, the potential to transplant insulin-producing cells could offer hope for a long-term cure. The discovery of a marker to help identify and isolate stem cells that can develop into insulin-producing cells in the pancreas would be a critical step forward and is described in an article in BioResearch Open Access, a new bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.

22 Aug 2012

Eco-friendly blood glucose monitor developed by Cambridge Consultants

A blood glucose monitor concept for diabetics that’s simpler to use, less cumbersome to carry and has a third of the environmental impact of traditional devices has been developed by Cambridge Consultants.

21 Aug 2012

Methyl-glyoxal could play a major role in abdominal obesity, insulin resistance and type 2 diabetes

Researchers at Mount Sinai School of Medicine have identified a common compound in the modern diet that could play a major role in the development of abdominal obesity, insulin resistance, and type 2 diabetes.

21 Aug 2012

Study demonstrates how Elesclomol blocks oxidative phosphorylation in melanoma

A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.

18 Aug 2012

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Teva Pharmaceutical Industries Ltd. announced today the launch of an authorized generic of ACTOplus met (pioglitazone/metformin tablets)15 mg/500 mg, 15 mg/850 mg.

18 Aug 2012

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

The U.S. Food and Drug Administration today approved the first generic version of Actos (pioglitazone hydrochloride) tablets. Along with diet and exercise, pioglitazone is used to improve blood glucose control in adults with type 2 diabetes.

18 Aug 2012

Glucose News and Research

Key facts about polycystic ovary syndrome

More findings on genetic complexity behind type 2 diabetes

Eco-friendly blood glucose monitor: an interview with Gemma Evans from Cambridge Consultants

A-kinase anchoring proteins influence levels of glucose in the body

Herpes virus eventually impairs glucose regulation

Blood glucose mobile apps may present visual and physical obstacles for older adults

Sleep apnea’s contribution to diabetic nephropathy needs attention

Healthy diets during infancy and early childhood can prevent obesity in future

Nipro Diagnostics, NextGen enter agreement for TRUEresult blood glucose monitoring system

Insulin glargine retards progression of atherosclerosis in high-risk people

Understanding photoreceptor proteins could lead to cancer drug therapy

Radiating fears over diabetes in childhood cancer survivors

Researchers create new type of biosensor that can detect glucose in saliva, tears

FDA warns consumers about potential health risks of two natural dietary supplements

SSEA4+ marker helps identify and isolate precursors of insulin-producing pancreatic cells

Eco-friendly blood glucose monitor developed by Cambridge Consultants

Methyl-glyoxal could play a major role in abdominal obesity, insulin resistance and type 2 diabetes

Study demonstrates how Elesclomol blocks oxidative phosphorylation in melanoma

Teva launches generic ACTOplus met to improve glucose control in adults with type 2 diabetes

Mylan Pharmaceuticals receives FDA approval for pioglitazone tablets to treat type 2 diabetes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News